QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

DCTH

QT72Delcath Systems, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
11.69
-0.24-2.01%
OverviewShort InterestFilings
DCTHQT72Delcath Systems, Inc.·NASDAQ
OverviewShort InterestFilings
11.69-2.01%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)0.01
Insider Own-
Shs Outstand-
Perf Week-0.68%
Market Cap407.01MForward P/E-EPS next Y-0.48Insider Trans-Shs Float-Perf Month7.74%
Enterprise Value-PEG-EPS next Q-0.09Inst Own-Short Float-Perf Quarter25.16%
Income-P/S-EPS this Y-6033.30%Inst Trans-Short Ratio-Perf Half Y16.55%
Sales-P/B-EPS next Y18.82%ROA-Short Interest-Perf YTD15.74%
Book/sh-P/C-EPS next 5Y-ROE-52W High14.62 -20.04%Perf Year-20.10%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-52W Low8.12 43.97%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y204.86% 111.68%Gross Margin-Volatility2.51% 3.60%Perf 5Y-
Dividend TTM-EV/Sales-EPS Y/Y TTM101.08%Oper. Margin-ATR (14)0.59Perf 10Y-
Dividend Ex-Date-Quick Ratio-Sales Y/Y TTM145.95%Profit Margin-RSI (14)56.87Recom2.36
Dividend Gr. 3/5Y-Current Ratio-EPS Q/Q-SMA204.79%Beta1.68Target Price23.00
Payout-Debt/Eq-Sales Q/Q25.00%SMA506.22%Rel Volume1.26Prev Close11.93
Employees96LT Debt/Eq0.01EarningsAug 05SMA20014.13%Avg Volume460.97KPrice11.69
IPO DateMay 03, 2018Option/ShortYes / YesEPS/Sales Surpr.68.09% 4.17%Net Debt/EBITDA-Volume582,700Change-2.01%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-26-26ReiteratedEvercore ISI$27
Feb-26-26ReiteratedBTIGBuy$19
Oct-21-25ReiteratedCraig-HallumBuy$24 → $20
Oct-20-25ReiteratedH.C. Wainwright$31 → $30
Mar-07-25ReiteratedH.C. Wainwright$22 → $24
May-15-24ReiteratedH.C. Wainwright$22
May-03-13DowngradeJMP SecuritiesMarket Outperform → Perform
May-03-13DowngradeCowen & Co.Outperform → Underperform
May-03-13DowngradeWedbushOutperform → Neutral
May-03-13DowngradeRoth CapitalBuy → Sell
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue918537
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A13126
Gross Profit787331
Selling, General and Administrative Excl. Other454430
Research and Development342914
Other Operating Expense00-1
Operating Income-11-12
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)-4-314
Net Income Before Taxes14-26
Income Taxes210
Consolidated Net Income13-26
Net Income From Continuing Operations13-26
Net Income13-26
EPS (Recurring)0.020.08-0.93
EPS (Basic, Before Extraordinaries)0.020.08-0.93
EPS (Diluted)0.010.07-0.93
EBITDA14-26
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio1,169.00149.41—
Price To Sales Ratio4.624.28—
Gross Margin85.7185.8883.78
Operating Margin-1.101.18-32.43
Net Margin1.103.53-70.27
Shares Outstanding363629
Market Capitalization421364—
Operating Lease Expense
———
Insider Trading Volume
$12.21$11.08$9.95$8.82$7.69● Close Price0.00K37.58K75.16K112.75K150.33KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Pennell SandraChief Financial OfficerMar 06 '26Buy9.045,53350,01877,018Mar 06 12:00 AM
MICHEL GERARD JCHIEF EXECUTIVE OFFICERMar 02 '26Buy8.9611,200100,309342,034Mar 03 12:00 AM
Sylvester John RichardDirectorNov 21 '25Buy8.894,38638,99214,936Nov 25 12:00 AM
MICHEL GERARD JCHIEF EXECUTIVE OFFICERNov 11 '25Buy8.5311,50098,049330,834Nov 13 12:00 AM
Vukovic VojoCHIEF MEDICAL OFFICERJun 12 '25Option Exercise4.7884,000401,520168,882Jun 13 12:00 AM
Aharon GilDirectorMay 05 '25Option Exercise10.00400,0004,000,0003,413,468May 09 12:00 AM
SALAMON STEVEN A JDirectorMay 05 '25Option Exercise10.00400,0004,000,0003,413,468May 09 12:00 AM
Rosalind Advisors, Inc.DirectorMay 05 '25Option Exercise10.00400,0004,000,0003,413,468May 09 12:00 AM
SALAMON STEVEN A JDirectorDec 24 '24Option Exercise0.01603,9546,0401,323,919Dec 27 12:00 AM
Aharon GilDirectorDec 24 '24Option Exercise0.01603,9546,0401,323,919Dec 26 12:00 AM
Rosalind Advisors, Inc.DirectorDec 24 '24Option Exercise0.01603,9546,0401,323,919Dec 26 12:00 AM
Aharon GilDirectorOct 30 '24Option Exercise1000.00500500,0000Nov 01 12:00 AM
SALAMON STEVEN A JDirectorOct 30 '24Option Exercise1000.00500500,0000Nov 01 12:00 AM
Rosalind Advisors, Inc.DirectorOct 30 '24Option Exercise1000.00500500,0000Nov 01 12:00 AM
MICHEL GERARD JCHIEF EXECUTIVE OFFICEROct 22 '24Option Exercise6.0033,332199,992319,334Oct 23 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR